{"id":369633,"date":"2025-09-01T20:13:26","date_gmt":"2025-09-01T20:13:26","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-johnson-johnson-2\/"},"modified":"2025-09-01T20:13:26","modified_gmt":"2025-09-01T20:13:26","slug":"how-to-buy-johnson-johnson-2","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/","title":{"rendered":"Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334090,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-369633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Johnson & Johnson (JNJB34) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin; mevcut fiyat trendleri, kazan\u00e7 etkisi ve 2025-2030 uzun vadeli yat\u0131r\u0131m stratejileri \u00fczerine uzman analizleri.","description_source":{"label":"Description","type":"textarea","formatted_value":"Johnson & Johnson (JNJB34) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin; mevcut fiyat trendleri, kazan\u00e7 etkisi ve 2025-2030 uzun vadeli yat\u0131r\u0131m stratejileri \u00fczerine uzman analizleri."},"intro":"Sa\u011fl\u0131k tarihinin bir par\u00e7as\u0131na sahip olmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Johnson & Johnson (JNJB34), ila\u00e7 d\u00fcnyas\u0131nda en istikrarl\u0131 ve yenilik\u00e7i yat\u0131r\u0131mlardan birini temsil ediyor. Band-Aid ve Tylenol gibi ikonik markalar\u0131n yan\u0131 s\u0131ra ileri d\u00fczey kanser tedavileriyle, bu \u015firket d\u00fcnya \u00e7ap\u0131nda hayatlara dokunuyor. 2025 i\u00e7in mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Sa\u011fl\u0131k tarihinin bir par\u00e7as\u0131na sahip olmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Johnson & Johnson (JNJB34), ila\u00e7 d\u00fcnyas\u0131nda en istikrarl\u0131 ve yenilik\u00e7i yat\u0131r\u0131mlardan birini temsil ediyor. Band-Aid ve Tylenol gibi ikonik markalar\u0131n yan\u0131 s\u0131ra ileri d\u00fczey kanser tedavileriyle, bu \u015firket d\u00fcnya \u00e7ap\u0131nda hayatlara dokunuyor. 2025 i\u00e7in mevcut hisse performans\u0131ndan ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi detayland\u0131raca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Johnson & Johnson Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla Johnson & Johnson (JNJ), NYSE'de <strong>177,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>21 Ekim 2025<\/strong> kesinlikle kritik\u2014bu tarihte JNJ \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar anl\u0131k fiyat hareketleri yarat\u0131r ve ticaret haftan\u0131z\u0131 \u015fekillendirebilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 JNJ Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>16 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>172,50 $<\/td><td><strong>%2,7 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>Intra-Cellular Sat\u0131n Al\u0131m\u0131<\/td><td>168,20 $<\/td><td><strong>%1,8 Art\u0131\u015f<\/strong> (stratejik hamle)<\/td><\/tr> <tr><td>\u015eubat 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>165,80 $<\/td><td><strong>%4,1 Art\u0131\u015f<\/strong> (g\u00fc\u00e7l\u00fc rehberlik)<\/td><\/tr> <\/tbody> <\/table> <p>Desen a\u00e7\u0131k: pozitif s\u00fcrprizler anl\u0131k s\u0131\u00e7ramalar yarat\u0131rken, hafif tahmin a\u015fmalar\u0131 bile istikrarl\u0131 kazan\u00e7lar sa\u011fl\u0131yor. Temmuz raporu tam da bunu g\u00f6sterdi\u2014tahminleri 0,09 $ a\u015fmas\u0131, hisseyi sonraki hafta boyunca istikrarl\u0131 \u015fekilde y\u00fckseltti.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3> <p>Johnson & Johnson hisseleri etkileyici bir <strong>%22,46 y\u0131lba\u015f\u0131ndan itibaren getiri<\/strong> sa\u011flad\u0131, kazan\u00e7lar\u0131n \u00e7o\u011fu ikinci \u00e7eyrekte yo\u011funla\u015ft\u0131:<\/p> <ul> <li><strong>Mart<\/strong>: 158,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>May\u0131s<\/strong>: 169,80 $ (sat\u0131n alma haberi ivmesi)<\/li> <li><strong>Temmuz<\/strong>: 175,40 $ (g\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7 tepkisi)<\/li> <li><strong>A\u011fustos<\/strong>: 177,98 $ (22 A\u011fustos'ta t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li> <\/ul> <p>Bu s\u00fcrekli y\u00fckseli\u015fi ne tetikledi? \u00dc\u00e7 fakt\u00f6r bu performans\u0131 sa\u011flad\u0131:<\/p> <ol> <li><strong>Operasyonel m\u00fckemmeliyet<\/strong>: 2. \u00e7eyrekte %5,8 sat\u0131\u015f b\u00fcy\u00fcmesi, 23,7 milyar $<\/li> <li><strong>Stratejik sat\u0131n almalar<\/strong>: Intra-Cellular Therapies 0,7 milyar $ ek sat\u0131\u015f getirdi<\/li> <li><strong>\u0130la\u00e7 hatt\u0131 ilerlemesi<\/strong>: Myastenia gravis i\u00e7in IMAAVY dahil \u00e7oklu ila\u00e7 onaylar\u0131<\/li> <\/ol> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 185-195 $ (g\u00fc\u00e7l\u00fc tatil performans\u0131 + ila\u00e7 hatt\u0131 kataliz\u00f6rleri) \u2192 <strong>AL<\/strong><\/li> <li><strong>2026<\/strong>: 200-215 $ (Hindistan pazar geni\u015flemesi + biyobenzer savunmas\u0131)<\/li> <li><strong>2028<\/strong>: 240-260 $ (ya\u015flanan n\u00fcfus talebi + robotik cerrahi benimsemesi)<\/li> <li><strong>2030<\/strong>: 280-310 $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi)<\/li> <\/ul> <p>14 analist aras\u0131nda ortak g\u00f6r\u00fc\u015f <strong>\"Al\" tavsiyesi<\/strong> olup ortalama fiyat hedefi yakla\u015f\u0131k 176,43 $ seviyesinde, hedefler ise 152 $ ile 215 $ aras\u0131nda geni\u015f bir aral\u0131kta. Mevcut fiyat, Ekim kazan\u00e7 kataliz\u00f6r\u00fc \u00f6ncesi birikim i\u00e7in ideal konumda.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Yeni FDA y\u00f6netimi onay standartlar\u0131n\u0131 y\u00fckseltiyor<\/li> <li><strong>Hukuki y\u00fck<\/strong>: On binlerce talk davas\u0131, 10 milyar $+ potansiyel y\u00fck\u00fcml\u00fcl\u00fck<\/li> <li><strong>Biyobenzer rekabeti<\/strong>: Stelara ve Tremfya jenerik bask\u0131s\u0131 alt\u0131nda<\/li> <li><strong>\u00c7in engelleri<\/strong>: Hacim bazl\u0131 sat\u0131n alma politikalar\u0131 MedTech b\u00fcy\u00fcmesini s\u0131n\u0131rl\u0131yor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3> <ul> <li><strong>Y\u00fckseltilmi\u015f rehberlik<\/strong>: Y\u0131ll\u0131k sat\u0131\u015f beklentisi 2 milyar $ art\u0131\u015fla %5,4 b\u00fcy\u00fcme<\/li> <li><strong>Yenilik tan\u0131nmas\u0131<\/strong>: Fortune'un En Yenilik\u00e7i \u015eirketler listesinde 13. s\u0131rada<\/li> <li><strong>\u0130la\u00e7 hatt\u0131 ivmesi<\/strong>: CARVYKTI multipl miyelomda umut vaat ediyor<\/li> <li><strong>\u00dcretim yat\u0131r\u0131m\u0131<\/strong>: Kuzey Carolina tesisine 2 milyar $ taahh\u00fct<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Dolar maliyeti ortalamas\u0131<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 21 Ekim'i yak\u0131ndan takip edin\u2014rapor sonras\u0131 %3-5 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li> <li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: JNJ hisselerini toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %15'inin alt\u0131nda tutun<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"JNJ ticareti, ilk yard\u0131m \u00fcr\u00fcnleri gibi\u2014uzun vadeli iyile\u015fme i\u00e7in harika, ama kazan\u00e7 volatilitesinde acil cerrahi yapmaya kalkmay\u0131n!\"<\/li> <\/ol> <h2>\u2705 Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Do\u011frulamay\u0131 tamamlay\u0131n<\/td><td>H\u0131zl\u0131 hesap onay\u0131 i\u00e7in kimli\u011finizi haz\u0131r tutun<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td><td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n\u201450 $ bile yeterli<\/td><\/tr> <tr><td>4<\/td><td>\"JNJ\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Limit emri belirleyin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 (\u00f6rne\u011fin 178 $) belirtin<\/td><\/tr> <tr><td>6<\/td><td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td><td>\u0130\u015flem ba\u015f\u0131na %0,5'in alt\u0131nda komisyon hedefleyin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td><td>Emir detaylar\u0131n\u0131 onaylayarak tamamlay\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Fiyat uyar\u0131lar\u0131 kurun<\/td><td>170 $ destek ve 185 $ diren\u00e7 seviyelerini takip edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, yeni ba\u015flayanlar i\u00e7in hisse senedi eri\u015fimini kolayla\u015ft\u0131r\u0131r:<\/p> <ul> <li><strong>Minimum depozito<\/strong>: Sadece 5 $ ile stratejileri risksiz test edin<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Herhangi bir resmi kimlikle 1 dakikal\u0131k KYC<\/li> <li><strong>\u00c7ekim esnekli\u011fi<\/strong>: Kripto, e-c\u00fczdanlar, banka kartlar\u0131 dahil 100+ se\u00e7enek<\/li> <li><strong>Par\u00e7al\u0131 hisse<\/strong>: Tam hisse paras\u0131 olmadan JNJ par\u00e7alar\u0131 sat\u0131n al\u0131n<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, <strong>Johnson & Johnson (JNJB34) hisse senedi yat\u0131r\u0131m\u0131n\u0131z\u0131<\/strong> \u00f6zellikle kritik kazan\u00e7 duyurular\u0131n\u0131 zamanlarken kolayla\u015ft\u0131r\u0131r.<\/p> <h2>\ud83c\udf0d 2025'te Johnson & Johnson: Sa\u011fl\u0131kta Yenilik Motoru<\/h2> <p>Johnson & Johnson, benzersiz \u00e7ift yap\u0131s\u0131yla k\u00fcresel sa\u011fl\u0131kta liderdir: <strong>Yenilik\u00e7i \u0130la\u00e7lar<\/strong> (ila\u00e7lar) ve <strong>MedTech<\/strong> (cihazlar ve tan\u0131). \u015eirketin 426,52 milyar $ piyasa de\u011feri, g\u00fc\u00e7l\u00fc operasyonel performansa dayal\u0131 olarak yak\u0131n zamanda y\u00fckseltilen tam y\u0131l rehberli\u011fiyle sa\u011fl\u0131k devi konumunu yans\u0131t\u0131yor.<\/p> <p>\u015eirketin yenilik altyap\u0131s\u0131, kardiyolojiden kanser bak\u0131m\u0131na kadar at\u0131l\u0131mlar sa\u011flayan 4 Yenilik Merkezi ve d\u00fcnya \u00e7ap\u0131nda 13 JLABS kulu\u00e7ka merkezini kaps\u0131yor. Son tamamlanan Intra-Cellular Therapies sat\u0131n al\u0131m\u0131, n\u00f6robilim tedavilerinde stratejik konumlanmay\u0131 g\u00f6steriyor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Johnson & Johnson'\u0131n Paris merkezinde, \u00e7al\u0131\u015fanlar\u0131n her kat\u0131n hangi imza kokusunu yayaca\u011f\u0131na haftal\u0131k oy verdi\u011fi parf\u00fcm da\u011f\u0131tan asans\u00f6rler bulunuyor\u2014kurumsal hareketlili\u011fi, t\u00fcketici \u00fcr\u00fcnleri miras\u0131n\u0131 yans\u0131tan duyusal bir deneyime d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Johnson &#038; Johnson Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla Johnson &#038; Johnson (JNJ), NYSE&#8217;de <strong>177,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>21 Ekim 2025<\/strong> kesinlikle kritik\u2014bu tarihte JNJ \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar anl\u0131k fiyat hareketleri yarat\u0131r ve ticaret haftan\u0131z\u0131 \u015fekillendirebilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 JNJ Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>16 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>172,50 $<\/td>\n<td><strong>%2,7 Art\u0131\u015f<\/strong> (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>Intra-Cellular Sat\u0131n Al\u0131m\u0131<\/td>\n<td>168,20 $<\/td>\n<td><strong>%1,8 Art\u0131\u015f<\/strong> (stratejik hamle)<\/td>\n<\/tr>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>165,80 $<\/td>\n<td><strong>%4,1 Art\u0131\u015f<\/strong> (g\u00fc\u00e7l\u00fc rehberlik)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen a\u00e7\u0131k: pozitif s\u00fcrprizler anl\u0131k s\u0131\u00e7ramalar yarat\u0131rken, hafif tahmin a\u015fmalar\u0131 bile istikrarl\u0131 kazan\u00e7lar sa\u011fl\u0131yor. Temmuz raporu tam da bunu g\u00f6sterdi\u2014tahminleri 0,09 $ a\u015fmas\u0131, hisseyi sonraki hafta boyunca istikrarl\u0131 \u015fekilde y\u00fckseltti.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3>\n<p>Johnson &#038; Johnson hisseleri etkileyici bir <strong>%22,46 y\u0131lba\u015f\u0131ndan itibaren getiri<\/strong> sa\u011flad\u0131, kazan\u00e7lar\u0131n \u00e7o\u011fu ikinci \u00e7eyrekte yo\u011funla\u015ft\u0131:<\/p>\n<ul>\n<li><strong>Mart<\/strong>: 158,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>May\u0131s<\/strong>: 169,80 $ (sat\u0131n alma haberi ivmesi)<\/li>\n<li><strong>Temmuz<\/strong>: 175,40 $ (g\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7 tepkisi)<\/li>\n<li><strong>A\u011fustos<\/strong>: 177,98 $ (22 A\u011fustos&#8217;ta t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi)<\/li>\n<\/ul>\n<p>Bu s\u00fcrekli y\u00fckseli\u015fi ne tetikledi? \u00dc\u00e7 fakt\u00f6r bu performans\u0131 sa\u011flad\u0131:<\/p>\n<ol>\n<li><strong>Operasyonel m\u00fckemmeliyet<\/strong>: 2. \u00e7eyrekte %5,8 sat\u0131\u015f b\u00fcy\u00fcmesi, 23,7 milyar $<\/li>\n<li><strong>Stratejik sat\u0131n almalar<\/strong>: Intra-Cellular Therapies 0,7 milyar $ ek sat\u0131\u015f getirdi<\/li>\n<li><strong>\u0130la\u00e7 hatt\u0131 ilerlemesi<\/strong>: Myastenia gravis i\u00e7in IMAAVY dahil \u00e7oklu ila\u00e7 onaylar\u0131<\/li>\n<\/ol>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 185-195 $ (g\u00fc\u00e7l\u00fc tatil performans\u0131 + ila\u00e7 hatt\u0131 kataliz\u00f6rleri) \u2192 <strong>AL<\/strong><\/li>\n<li><strong>2026<\/strong>: 200-215 $ (Hindistan pazar geni\u015flemesi + biyobenzer savunmas\u0131)<\/li>\n<li><strong>2028<\/strong>: 240-260 $ (ya\u015flanan n\u00fcfus talebi + robotik cerrahi benimsemesi)<\/li>\n<li><strong>2030<\/strong>: 280-310 $ (k\u00fcresel sa\u011fl\u0131k altyap\u0131s\u0131 b\u00fcy\u00fcmesi)<\/li>\n<\/ul>\n<p>14 analist aras\u0131nda ortak g\u00f6r\u00fc\u015f <strong>&#8220;Al&#8221; tavsiyesi<\/strong> olup ortalama fiyat hedefi yakla\u015f\u0131k 176,43 $ seviyesinde, hedefler ise 152 $ ile 215 $ aras\u0131nda geni\u015f bir aral\u0131kta. Mevcut fiyat, Ekim kazan\u00e7 kataliz\u00f6r\u00fc \u00f6ncesi birikim i\u00e7in ideal konumda.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Yeni FDA y\u00f6netimi onay standartlar\u0131n\u0131 y\u00fckseltiyor<\/li>\n<li><strong>Hukuki y\u00fck<\/strong>: On binlerce talk davas\u0131, 10 milyar $+ potansiyel y\u00fck\u00fcml\u00fcl\u00fck<\/li>\n<li><strong>Biyobenzer rekabeti<\/strong>: Stelara ve Tremfya jenerik bask\u0131s\u0131 alt\u0131nda<\/li>\n<li><strong>\u00c7in engelleri<\/strong>: Hacim bazl\u0131 sat\u0131n alma politikalar\u0131 MedTech b\u00fcy\u00fcmesini s\u0131n\u0131rl\u0131yor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3>\n<ul>\n<li><strong>Y\u00fckseltilmi\u015f rehberlik<\/strong>: Y\u0131ll\u0131k sat\u0131\u015f beklentisi 2 milyar $ art\u0131\u015fla %5,4 b\u00fcy\u00fcme<\/li>\n<li><strong>Yenilik tan\u0131nmas\u0131<\/strong>: Fortune&#8217;un En Yenilik\u00e7i \u015eirketler listesinde 13. s\u0131rada<\/li>\n<li><strong>\u0130la\u00e7 hatt\u0131 ivmesi<\/strong>: CARVYKTI multipl miyelomda umut vaat ediyor<\/li>\n<li><strong>\u00dcretim yat\u0131r\u0131m\u0131<\/strong>: Kuzey Carolina tesisine 2 milyar $ taahh\u00fct<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Dolar maliyeti ortalamas\u0131<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 21 Ekim&#8217;i yak\u0131ndan takip edin\u2014rapor sonras\u0131 %3-5 d\u00fc\u015f\u00fc\u015fte al\u0131m yap\u0131n<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: JNJ hisselerini toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %15&#8217;inin alt\u0131nda tutun<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;JNJ ticareti, ilk yard\u0131m \u00fcr\u00fcnleri gibi\u2014uzun vadeli iyile\u015fme i\u00e7in harika, ama kazan\u00e7 volatilitesinde acil cerrahi yapmaya kalkmay\u0131n!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve par\u00e7al\u0131 hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Do\u011frulamay\u0131 tamamlay\u0131n<\/td>\n<td>H\u0131zl\u0131 hesap onay\u0131 i\u00e7in kimli\u011finizi haz\u0131r tutun<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n\u201450 $ bile yeterli<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;JNJ&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emri belirleyin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 (\u00f6rne\u011fin 178 $) belirtin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u00dccretleri g\u00f6zden ge\u00e7irin<\/td>\n<td>\u0130\u015flem ba\u015f\u0131na %0,5&#8217;in alt\u0131nda komisyon hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>Emir detaylar\u0131n\u0131 onaylayarak tamamlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat uyar\u0131lar\u0131 kurun<\/td>\n<td>170 $ destek ve 185 $ diren\u00e7 seviyelerini takip edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, yeni ba\u015flayanlar i\u00e7in hisse senedi eri\u015fimini kolayla\u015ft\u0131r\u0131r:<\/p>\n<ul>\n<li><strong>Minimum depozito<\/strong>: Sadece 5 $ ile stratejileri risksiz test edin<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Herhangi bir resmi kimlikle 1 dakikal\u0131k KYC<\/li>\n<li><strong>\u00c7ekim esnekli\u011fi<\/strong>: Kripto, e-c\u00fczdanlar, banka kartlar\u0131 dahil 100+ se\u00e7enek<\/li>\n<li><strong>Par\u00e7al\u0131 hisse<\/strong>: Tam hisse paras\u0131 olmadan JNJ par\u00e7alar\u0131 sat\u0131n al\u0131n<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, <strong>Johnson &#038; Johnson (JNJB34) hisse senedi yat\u0131r\u0131m\u0131n\u0131z\u0131<\/strong> \u00f6zellikle kritik kazan\u00e7 duyurular\u0131n\u0131 zamanlarken kolayla\u015ft\u0131r\u0131r.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Johnson &#038; Johnson: Sa\u011fl\u0131kta Yenilik Motoru<\/h2>\n<p>Johnson &#038; Johnson, benzersiz \u00e7ift yap\u0131s\u0131yla k\u00fcresel sa\u011fl\u0131kta liderdir: <strong>Yenilik\u00e7i \u0130la\u00e7lar<\/strong> (ila\u00e7lar) ve <strong>MedTech<\/strong> (cihazlar ve tan\u0131). \u015eirketin 426,52 milyar $ piyasa de\u011feri, g\u00fc\u00e7l\u00fc operasyonel performansa dayal\u0131 olarak yak\u0131n zamanda y\u00fckseltilen tam y\u0131l rehberli\u011fiyle sa\u011fl\u0131k devi konumunu yans\u0131t\u0131yor.<\/p>\n<p>\u015eirketin yenilik altyap\u0131s\u0131, kardiyolojiden kanser bak\u0131m\u0131na kadar at\u0131l\u0131mlar sa\u011flayan 4 Yenilik Merkezi ve d\u00fcnya \u00e7ap\u0131nda 13 JLABS kulu\u00e7ka merkezini kaps\u0131yor. Son tamamlanan Intra-Cellular Therapies sat\u0131n al\u0131m\u0131, n\u00f6robilim tedavilerinde stratejik konumlanmay\u0131 g\u00f6steriyor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Johnson &#038; Johnson&#8217;\u0131n Paris merkezinde, \u00e7al\u0131\u015fanlar\u0131n her kat\u0131n hangi imza kokusunu yayaca\u011f\u0131na haftal\u0131k oy verdi\u011fi parf\u00fcm da\u011f\u0131tan asans\u00f6rler bulunuyor\u2014kurumsal hareketlili\u011fi, t\u00fcketici \u00fcr\u00fcnleri miras\u0131n\u0131 yans\u0131tan duyusal bir deneyime d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor!<\/p>\n"},"faq":[{"question":"Johnson & Johnson hisseleri nereden al\u0131nabilir?","answer":"Johnson & Johnson hisseleri, NYSE'de i\u015flem g\u00f6ren bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"JNJ hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Bir\u00e7ok platformda par\u00e7al\u0131 hisse al\u0131m\u0131 m\u00fcmk\u00fcn oldu\u011fundan, minimum yat\u0131r\u0131m tutar\u0131 5 $ gibi d\u00fc\u015f\u00fck seviyelerde olabilir."},{"question":"Johnson & Johnson hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re, 2025 sonunda 185-195 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 280-310 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Johnson & Johnson hisseleri al\u0131rken nelere dikkat etmeliyim?","answer":"Reg\u00fclasyon riskleri, hukuki davalar, biyobenzer rekabeti ve \u00c7in pazar\u0131ndaki zorluklar gibi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayan biri Johnson & Johnson hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"D\u00fczenli ve sabit tutarlarda yat\u0131r\u0131m yaparak, kazan\u00e7 raporlar\u0131n\u0131 takip ederek ve portf\u00f6y \u00e7e\u015fitlendirmesi yaparak yat\u0131r\u0131m yap\u0131lmas\u0131 \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Johnson & Johnson hisseleri nereden al\u0131nabilir?","answer":"Johnson & Johnson hisseleri, NYSE'de i\u015flem g\u00f6ren bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"JNJ hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Bir\u00e7ok platformda par\u00e7al\u0131 hisse al\u0131m\u0131 m\u00fcmk\u00fcn oldu\u011fundan, minimum yat\u0131r\u0131m tutar\u0131 5 $ gibi d\u00fc\u015f\u00fck seviyelerde olabilir."},{"question":"Johnson & Johnson hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re, 2025 sonunda 185-195 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 280-310 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Johnson & Johnson hisseleri al\u0131rken nelere dikkat etmeliyim?","answer":"Reg\u00fclasyon riskleri, hukuki davalar, biyobenzer rekabeti ve \u00c7in pazar\u0131ndaki zorluklar gibi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayan biri Johnson & Johnson hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"D\u00fczenli ve sabit tutarlarda yat\u0131r\u0131m yaparak, kazan\u00e7 raporlar\u0131n\u0131 takip ederek ve portf\u00f6y \u00e7e\u015fitlendirmesi yaparak yat\u0131r\u0131m yap\u0131lmas\u0131 \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Johnson &amp; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson &amp; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson &amp; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T20:13:26+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T20:13:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\",\"name\":\"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"datePublished\":\"2025-09-01T20:13:26+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/","og_locale":"tr_TR","og_type":"article","og_title":"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T20:13:26+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T20:13:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/","name":"Johnson & Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r - Johnson & Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","datePublished":"2025-09-01T20:13:26+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals12.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-johnson-johnson-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Johnson &#038; Johnson (JNJB34) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Johnson &#038; Johnson (JNJB34) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":369635,"slug":"how-to-buy-johnson-johnson-2","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Johnson & Johnson (JNJB34) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Johnson & Johnson (JNJB34)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-johnson-johnson-2\/"},"pt_AA":{"locale":"pt_AA","id":369632,"slug":"how-to-buy-johnson-johnson-2","post_title":"Como comprar a\u00e7\u00f5es da Johnson & Johnson (JNJB34) - Investimento em a\u00e7\u00f5es da Johnson & Johnson (JNJB34)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-johnson-johnson-2\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=369633"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334090"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=369633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=369633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=369633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}